Investigating adrenal tumors and their treatments

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on understanding the pathogenesis of adrenal tumors, including conditions such as adrenocortical carcinoma, Cushing syndrome, Conn syndrome, and pheochromocytoma. It aims to evaluate various therapeutic options available for patients diagnosed with these tumors. By analyzing the underlying mechanisms and treatment responses, the study seeks to provide insights that could improve patient management and outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* adrenal tumor detected by imaging

Exclusion Criteria:

Where it's running

• University of Wuerzburg
  Würzburg, Germany Recruiting

Study contacts

• Principal investigator: Martin Fassnacht, MD — U of Wuerzburg
• Study coordinator: Martin Fassnacht, MD
• Email: fassnacht_m@medizin.uni-wuerzburg.de
• Phone: 49-931-201-36507

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Registry for Rare Diseases

  This study is creating a detailed registry to collect information on rare diseases like amyloidosis and sarcoidosis to help improve how they are diagnosed and treated.

  Recruiting Hospital Italiano de Buenos Aires · Buenos Aires, Buenos Aires · NCT06573723

• Gene modified immune cells for treating advanced melanoma and metastatic solid tumors

  This study is testing if modified immune cells can safely target and attack advanced melanoma and other solid tumors in patients after they receive chemotherapy.

  Recruiting at 3 sites Phase 1 Stanford University · Duarte, California and 2 other locations · NCT04119024

• Myokines in metabolic and endocrine diseases linked to sarcopenia

  This study tests whether myokines can serve as biomarkers or drivers of sarcopenia and sarcopenic obesity in people with metabolic or endocrine diseases.

  Recruiting Cliniques universitaires Saint-Luc- Université Catholique de Louvain · Woluwe-Saint-Pierre - Sint-Pieters-Woluwe · NCT07703683

• Belzutifan and catecholamine metabolism in pheochromocytoma/paraganglioma

  This study tests whether Belzutifan can change how catecholamines are produced and broken down in adults with pheochromocytoma or paraganglioma.

  Recruiting Phase 2 Cambridge University Hospitals NHS Foundation Trust · Cambridge, Cambridgeshire · NCT07680205

• Endoscopic ultrasound-guided radiofrequency ablation for pancreatic and left adrenal lesions

  This will try EUS-guided radiofrequency ablation to control symptoms and hormone-related problems in adults with small pancreatic neuroendocrine tumors (including insulinomas) or certain left adrenal adenomas.

  Recruiting Herlev Hospital · Herlev, Capital Region · NCT07272187

• Osilodrostat for high blood pressure caused by Cushing's syndrome

  This study tests whether osilodrostat can lower high blood pressure in adults with Cushing's syndrome-related hypercortisolemia.

  Recruiting at 3 sites Phase 4 Recordati Group · Jacksonville, Florida and 2 other locations · NCT07247162

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.